Collecting and Storing Blood Samples From Patients With Cancer

Sponsor
University of Medicine and Dentistry of New Jersey (Other)
Overall Status
Withdrawn
CT.gov ID
NCT00900120
Collaborator
National Cancer Institute (NCI) (NIH)
0
86

Study Details

Study Description

Brief Summary

RATIONALE: Collecting and storing samples of blood from patients with cancer to test in the laboratory may help the study of cancer in the future.

PURPOSE: This research study is collecting and storing blood samples from patients with cancer.

Detailed Description

OBJECTIVES:
  • To establish a repository for long-term storage of DNA obtained from patients treated at the Cancer Institute of New Jersey.

  • To establish a mechanism whereby investigators can analyze correlations between genetic polymorphisms and clinical outcomes (e.g., response to treatment).

OUTLINE: Additional blood samples are collected for banking from patients while they are scheduled for routine blood draw as a part of their normal care. Samples are stored in a secure place under the control of the Cancer Institute of New Jersey Tissue Retrieval service. The samples may be used for DNA, RNA, or protein extraction and analyses, as well as generation of cell lines.

Demographic data (ethnicity, race, age, and sex), diagnosis, family history, and previous treatments (chemotherapy, radiation, and surgery) are recorded on the case report form and kept in a secure location in the Office of Human Research Services (OHRS).

Patients may have their samples removed and destroyed at any time.

Study Design

Study Type:
Observational
Actual Enrollment :
0 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Banking DNA for Analysis of Genetic Polymorphisms in Patients With Cancer
Study Start Date :
Mar 1, 2004
Actual Primary Completion Date :
May 1, 2011
Actual Study Completion Date :
May 1, 2011

Outcome Measures

Primary Outcome Measures

  1. DNA repository for long-term storage of DNA obtained from patients treated at the Cancer Institute of New Jersey [Indefinite]

  2. Investigative mechanism to allow correlations between genetic polymorphisms and clinical outcomes [Indefinite]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
DISEASE CHARACTERISTICS:
  • Histologically or cytologically confirmed malignancy or bone marrow disorder (i.e., myelodysplasia, myeloproliferative syndrome, or aplastic anemia)

  • Must be undergoing treatment or planning to undergo treatment at the Cancer Institute of New Jersey

PATIENT CHARACTERISTICS:
  • Not specified
PRIOR CONCURRENT THERAPY:
  • See Disease Characteristics

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Medicine and Dentistry of New Jersey
  • National Cancer Institute (NCI)

Investigators

  • Principal Investigator: Kim Hirshfield, MD, PhD, Rutgers Cancer Institute of New Jersey

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Medicine and Dentistry of New Jersey
ClinicalTrials.gov Identifier:
NCT00900120
Other Study ID Numbers:
  • 0220044856
  • P30CA072720
  • CINJ-000402
  • CINJ-IRB-4856
First Posted:
May 12, 2009
Last Update Posted:
Sep 21, 2021
Last Verified:
Sep 1, 2021
Keywords provided by University of Medicine and Dentistry of New Jersey
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 21, 2021